Li-Jia Zhi

Li-Jia Zhi

Auto-generated profile, based on publicly available information

Li-Jia Zhi

Department of Critical Care Medicine, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, China

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 April 2023 in Medicine
Verified
Journal Article
Open access
TTTian Tao
Tian Tao
JCJun Chen
Jun Chen
KLKunlan Long
Kunlan Long
LZLijia Mm Zhi
Lijia Mm Zhi
SZSong Zhang
Song Zhang
PGPeiyang Gao
Peiyang Gao
Rationale: Meningoencephalomyelitis and visceral dissemination infection are rare but life-threatening complications of either the primary infection or reactivation of varicella-zoster virus (VZV) in immunocompromised patients. To date, few studies have reported the co-existence of VZV meningoencephalomyelitis and the visceral dissemination of VZV infection. Patient concerns: A 23-year-old male was diagnosed with lupus nephritis class III and was being treated with oral prednisone and tacrolimus. The patient exhibited herpes zoster 21-day after the initiation of therapy and experienced unbearable abdominal pain and generalized seizures 11 days after the onset of a zoster rash. Magnetic resonance imaging showed progressive lesions in the cerebrum, brainstem, and cerebellum, as well as meningeal thickening and thoracic myelitis. Computed tomography showed pulmonary interstitial infiltration, partial intestinal dilatation, and effusion. Metagenomic next-generation sequencing revealed 198,269 and 152,222 VZV-specific reads in the cerebrospinal fluid and bronchoalveolar lavage fluid, respectively. Diagnoses: Based on the clinical and genetic findings, this patient was finally diagnosed with VZV meningoencephalomyelitis and visceral disseminated VZV infection. Interventions: The patient received intravenous acyclovir (0.5 g every 8 hours) combined with plasma exchange and intravenous immunoglobulin. Treatment against secondary bacterial and fungal infections, organ support therapy and rehabilitation training were given simultaneously. Outcome: The patient’s peripheral muscle strength did not improve and repeated metagenomic next-generation sequencing showed the persistence of VZV-specific reads in the cerebrospinal fluid. The patient finally abandoned therapy due to financial constraints at the 1-month follow-up. Lessons: Patients with autoimmune diseases receiving immunosuppressive therapy should be warned about the possibility of developing serious neurological infections and visceral disseminated VZV infections as side effects. Early diagnosis and the early initiation of intravenous acyclovir therapy are important for such cases.

10 September 2024 in Frontiers in Immunology
Verified
Journal Article
Open access
PDF file
XCXing-Yue Chen
Xing-Yue Chen
JCJun Chen
Jun Chen
KLKun-Lan Long
Kun-Lan Long
PDPeng Ding
Peng Ding
RLRong Li
Rong Li
LZLi-Jia Zhi
Li-Jia Zhi
Background: Bullous pemphigoid (BP) is the most common autoimmune blistering skin disease in humans, characterized by tense blisters, erosions, urticarial lesions, and itching on normal or erythematous skin. Many autoimmune diseases are considered comorbidities of BP, but clinical case reports of BP complicated by Sjögren’s syndrome are very scarce. Furthermore, cases of central nervous system infection secondary to both autoimmune diseases are even rarer.Case presentation: We report a 74-year-old woman diagnosed with bullous pemphigoid, who showed relief of active lesions after treatment with methylprednisolone and dupilumab injections. However, she was admitted for pulmonary infection during which she was diagnosed with Sjögren’s syndrome (SS). Subsequently, the patient developed altered consciousness, indicating a central nervous system infection. Adjustment of steroid dosage and aggressive antimicrobial therapy led to alleviation of symptoms.Conclusion: The coexistence of autoimmune subepidermal blistering diseases and SS is rare. The role of SS in the pathogenesis of skin lesions is unclear, and the relationship between these blistering diseases and SS remains elusive. Further research is needed to determine whether there are common pathological mechanisms between the two conditions.

11 October 2024 in Frontiers in Cardiovascular Medicine
Verified
Journal Article
Open access
PDF file
PDPeng Ding
Peng Ding
YZYuan Zhou
Yuan Zhou
MYMeijie Yang
Meijie Yang
SLSheng Li
Sheng Li
SZSong Zhang
Song Zhang
LZLijia Zhi
Lijia Zhi
Background: Genetic variation plays an extremely important pathogenic role in the development of venous thromboembolism (VTE). Genetic protein S (PS) deficiency caused by PROS1 gene mutation is an important risk factor for hereditary thrombophilia.Case introduction: In this case, we report a 28-year-old male patient who developed a severe pulmonary embolism during his visit. The patient had experienced one month of chest pains, coughing and hemoptysis symptoms. CTPA confirmed an acute pulmonary embolism with multiple filling defects in both pulmonary arteries. Ultrasound showed no thrombosis in the veins of both lower limbs. The patient's father and grandfather have a history of lower limb venous thrombosis. The patient was diagnosed with acute pulmonary embolism and pneumonia. The serum PS level significantly decreased (detection result: 10%, normal range: 77–143). Gene sequencing revealed a heterozygous missense mutation in PROS1 c.76+2_76+3del (base deletion), and further testing revealed that the genetic variation originated from his father. The patient was treated with heparin anticoagulant therapy, catheter thrombus aspiration, and catheter thrombolysis. After treatment, the patient's chest pain symptoms were relieved, and there were no symptoms such as difficulty breathing. On the 7th day of admission, the patient was transferred to a general hospital for further treatment.Conclusion: Hereditary thrombophilia caused by mutations in the PROS1 (c.76+2_76+3del) gene is extremely rare. In clinical practice, heparin and rivaroxaban treatment are beneficial.

8 October 2020 in Research Square
Verified
Preprint
Open access
PDF file
XAXing An
Xing An
XWXiangwen Weng
Xiangwen Weng
LLLi Li
Li Li
QHQingsong Huang
Qingsong Huang
KLKunlan Long
Kunlan Long
LZLijia Zhi
Lijia Zhi
Background: There has not been reported that prone position increases the risk of postoperative pancreatic fistula. We present a case of prone position leading to hyperthermia and pancreatic fistula in a patient with acute respiratory distress syndrome(ARDS) after laparoscopic radical gastrectomy(LRG) combined with heated intraperitoneal chemotherapy(HIPEC).Case presentation: A 68-year-old male developed moderate ARDS after LRG combined with HIPEC. Since low tidal volume and high positive end expiratory pressure(PEEP) ventilation could not improve oxygenation, prone ventilation was selected to improve heterogeneous lung injury. However, chills and fever appeared after the position change. Abdominal computed tomography (CT) showed that the mesenteric fat space in the middle abdomen was fuzzy, local exudation was increased, and the boundary of pancreas was not clear. The increase of amylase in peritoneal drainage fluid was 10 times higher than that in serum amylase. After communicating with the general surgeon, we learned that during the operation, the surgeon had opened the pancreatic capsule to clean the local lymph nodes. It was considered that prone position lead to the sharp increase of abdominal pressure, especially the change of peripancreatic pressure. The visceral organs of the abdominal cavity squeezed each other, the pancreatic tissue was compressed, the pancreatic juice extravasation occurred, and even aggravated the pancreatic fistula. In the follow-up treatment process, the patient were given continuous abdominal drainage and avoided prone position as far as possible. Since then, the patient's temperature tended to be stable. On the 10th day after the operation, the patient successfully withdrew from the ventilator and transferred to the general ward for further specialized treatment.Conclusion: Our case adds further concerns in ARDS patients after LRG combined with HIPEC, including the monitoring of postoperative pancreatic fistula and how to perform prone ventilation more safely.

30 June 2026 in Frontiers in Immunology
Verified
Journal Article
Open access
PDF file
XCXing-Yue Chen
Xing-Yue Chen
JCJun Chen
Jun Chen
LLLei Lv
Lei Lv
DJDa-Wei Jiang
Da-Wei Jiang
KLKunlan Long
Kunlan Long
LZLi-Jia Zhi
Li-Jia Zhi
Background: Immunoglobulin G (IgG) type 4-related disease (IgG4-RD) is a rare, chronic fibroinflammatory condition that can affect multiple organ systems. Cutaneous involvement in IgG4-RD is even rarer. Moreover, the clinical manifestations of primary IgG4-related skin disease (IgG4-RSD) are often atypical, making it easy for clinicians to misdiagnose or overlook the condition, leading to delays in diagnosis and treatment. Case presentation: We report the case of a 36-year-old male who was admitted to the hospital due to recurrent papules and pustules at multiple sites across the body for 8 years. He was misdiagnosed with hidradenitis suppurativa at an outside hospital and received long-term anti-infective therapy and irregular prednisone treatment, but experienced recurrent episodes. This admission was prompted by worsening skin lesions complicated by sepsis. Based on clinical clues including chronic recurrent skin lesions, poor response to anti-infective therapy, and symptom relief with corticosteroids but frequent relapses, we performed targeted serum IgG4 testing and skin biopsy, ultimately confirming the diagnosis of primary IgG4-RSD. After treatment with a standardized regimen of glucocorticoids combined with azathioprine as a steroid-sparing agent, the skin lesions significantly improved. At the 2-month follow-up after discharge, no new skin lesions developed, pre-existing lesions had largely healed, and serum IgG4 levels returned to normal. Conclusion: Primary IgG4-RSD is rare and diagnostically challenging, as it can mimic a wide range of diseases and its pathogenesis remains incompletely understood. A definitive diagnosis requires markedly elevated serum IgG levels, characteristic histopathological findings, and rigorous exclusion of mimicking disorders. Additionally, the condition tends to relapse during treatment. Therefore, enhancing clinicians’ understanding of IgG4-RD is crucial.